Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Percentage of patients reporting certain long-term bother (time D) in dependence on pretreatment (time A) or acute (time B and C) bother

From: Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study

  probability of long-term bother at time D
if bother already present vs. absent at time A/B/C [p-value]
great/moderate bother with: time A time B time C
dripping or leaking urine 6% vs. 8%
n.s.
19% vs. 3%
[0.001]
50% vs. 3%
[<0.001]
pain or burning on urination 0% vs. 6%
n.s.
11% vs. 1%
[0.001]
28% vs. 3%
[<0.001]
waking up to urinate 26% vs. 29%
n.s.
44% vs. 8%
[<0.001]
72% vs. 13%
[<0.001]
urinary function overall 7% vs. 16%
n.s.
24% vs. 5%
[<0.001]
50% vs. 7%
[<0.001]
urgency to have a bowel movement 21% vs. 13%
n.s.
25% vs. 5%
[<0.001]
50% vs. 6%
[<0.001]
losing control of stools 25% vs. 5%
n.s.
25% vs. 1%
[<0.001]
45% vs. 3%
[<0.001]
bloody stools - vs. 3%* 0% vs. 3%
n.s.
33% vs. 2%
[<0.001]
bowel habits overall 28% vs. 13%
n.s.
34% vs. 3%
[<0.001]
56% vs. 5%
[<0.001]
  1. Example: 56% of patients with great/moderate bother with bowel habits overall at time C report the same bother at time D; 5% of patients without great/moderate bother with bowel habits overall at time C report this bother at time D
  2. n.s. = not significant
  3. *no patients with great/moderate bother with bloody stools at time A